A federal judge in New York ruled that a lawsuit filed by current and former JPMorgan Chase & Co. employees regarding the company's health insurance plan can proceed. The lawsuit accuses the bank of breaching its fiduciary duties under the Employee Retirement Income Security Act (ERISA).
Plaintiffs allege JPMorgan failed to effectively negotiate lower prices for prescription drugs. This failure reportedly led to employees overpaying for medications.
The complaint specifically claims JPMorgan did not adequately manage its contract with pharmacy benefit manager CVS. This mismanagement allegedly resulted in inflated drug costs.
The case is part of a growing trend of litigation against large corporations over their management of employee health and drug benefits. While courts have dismissed similar cases against other major companies, the partial advancement of this suit marks a notable development.